🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 Just over 3 hours to go! Our highly anticipated webinar kicks off at 09:00 AM (EDT, New York, USA) on Tuesday, June 17, 2025. ⏳ Don’t miss out — register now for free and join us for cutting-edge insights: oaepublish.com/webreviewer/mt…

🚨 Join us live! MetALD: Opportunities and Changes 🌐 Free registration now open: oaepublish.com/webreviewer/mt…

Don’t miss the MetALD webinar “Opportunities and Challenges” on July 1! 🎉 Register now for FREE : oaepublish.com/webreviewer/mt… 👩‍⚕️ #MetALD #Livertwitter

📢 Don’t miss the upcoming webinar on MetALD: Opportunities and Challenges on July 1! Join leading experts to explore this emerging field. 🎓 Free registration via the link below: oaepublish.com/webreviewer/mt… #MetALD #Livertwitter #Hepatology

M&TOD has received its first Impact Factor: 3.9, placing us in Q2 and among the top 30% in the field! Thank you to all authors, reviewers, and editors for your support! 🙌 🔗 oaepublish.com/news/mtod.1205 #Metabolism #Livertwitter #obesity, #diabetes

📢 New Perspective by Prof. Christopher D. Byrne! Rethinking care models for MASLD—beyond liver health, tackling cardiometabolic risk through multisystem, community-based strategies. 🔗 Read here: oaepublish.com/articles/mtod.… #MASLD #livertwitter

🔍 New study compares primary B-RYGB, banded long-limb RYGB, and revisional B-RYGB at 1-year follow-up. 📖 Read more: oaepublish.com/articles/mtod.… #BariatricSurgery #Obesity #RYGB #MetabolicSurgery

🚨 Cancer therapies may worsen diabetic retinopathy — an underestimated and dangerous intersection of two major diseases. Learn which drugs are involved and why more research is urgently needed. 📖 Read now: oaepublish.com/articles/mtod.… #Diabetes #Cancer #Retinopathy #Oncology

🚨 Dive into metabolic primary liver cancer in adults — uncover risk factors & complex mechanisms behind #HCC & #Cholangiocarcinoma 🔬🧬. Early detection & personalized care are key! 🔑✨ Read now 👉oaepublish.com/articles/mtod.… #LiverCancer #NAFLD #MetabolicSyndrome

Missed it live? Catch the replay of Prof. Ashwani K. Singal’s powerful session on Managing MetALD from our recent webinar “MetALD: Opportunities and Challenges.” 📽️ Watch the full talk here: youtu.be/Y4UZJuslJFA?si… via YouTube #MetALD #Livertwitter #Hepatology

Now Available: Webinar Replay Watch Prof. Robert J. Wong’s insightful talk on the definition, prevalence, diagnosis, and prognosis of MetALD — a foundational overview from our MetALD: Opportunities and Challenges symposium. 📺 Don’t miss it: youtu.be/YadVfSCwI2U

🎥 Now live! Watch Prof. Winston Dunn's insightful talk on "Interaction of Risk Factors and Disease Modifiers" — a must-see for anyone interested in liver disease and precision medicine. Don’t miss it: youtu.be/L_oX_PPGAMk

🎥 Now available! Don’t miss the insightful talk by Dr. Luis Antonio Diaz on: “Liver Transplantation in #MetALD” 🔗 youtu.be/-qayG-NEcBM

🧪 New study alert! Bilirubin improves insulin resistance & reduces ectopic lipid deposition by targeting the #HSP90β/#SREBP axis. A promising therapeutic strategy for metabolic syndrome! 🔗oaepublish.com/articles/mtod.… #Metabolism #InsulinResistance #LipidMetabolism #Bilirubin

🎥 Now available! Watch Dr. Mads Israelsen’s insightful talk: "Clinical and Research Implications of MetALD and SLD Nomenclature." Don’t miss ▶️ youtu.be/B5UVDCNTt6Q #Livertwitter #MetALD #SLD #Hepatology

🧬 New insights into #MASLD! Epigenetic & epitranscriptomic regulators like SNAIL1, SLUG, and m6A modifications play pivotal roles in steatosis, liver injury & regeneration. Explore how these mechanisms drive MASLD/#MASH progression. 🔗 oaepublish.com/articles/mtod.… #Livertwitter

Is liver fibrosis a risk factor for gynecological cancers? Explore the latest insights on the link between liver disease and female reproductive #cancers, including breast cancer. Read now: oaepublish.com/articles/mtod.… #LiverFibrosis #GynecologicalCancers #MAFLD #NAFLD

🌍 Join us at the 3rd Euro Diabetes, Endocrinology & Metabolic Diseases Conference! 📅 Oct 27–28, 2025 📍 Italy A dynamic forum for leading experts, physicians & young researchers to connect, share, and collaborate. 🔗 diabetic.plenareno.com #Diabetes #Endocrinology

New Review Alert! Metabolic dysfunction-associated steatotic liver disease (MASLD) across the liver transplant cycle—challenges, organ allocation, post-LT outcomes & more. By Brian J. Wentworth 🔗 doi.org/10.20517/mtod.… #MASLD #LiverTransplant #Hepatology